Cargando…

Therapeutic potential of trehalose in neurodegenerative diseases: the knowns and unknowns

Detalles Bibliográficos
Autores principales:	Khalifeh, Masoomeh, Barreto, George E., Sahebkar, Amirhossein
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8343311/ https://www.ncbi.nlm.nih.gov/pubmed/33642389 http://dx.doi.org/10.4103/1673-5374.308085

Ejemplares similares

Disease-associated oligodendrocyte signatures in neurodegenerative disease: the known and unknown
por: Schuster, Kristen H., et al.
Publicado: (2023)

Cryptic or Silent? The Known Unknowns, Unknown Knowns, and Unknown Unknowns of Secondary Metabolism
por: Hoskisson, Paul A., et al.
Publicado: (2020)

Restless Legs Syndrome: Known Knowns and Known Unknowns
por: Antelmi, Elena, et al.
Publicado: (2022)

siRNA Therapeutics: Future Promise for Neurodegenerative Diseases
por: Amiri, Atefeh, et al.
Publicado: (2021)

Therapeutic potential of lysosomal cathepsins for neurodegenerative diseases
por: Prieto Huarcaya, Susy, et al.
Publicado: (2022)

Vaccination against SARS-CoV-2 and disease enhancement – knowns and unknowns
por: Zellweger, Raphaël M., et al.
Publicado: (2020)

Symptom tracking in endometriosis using digital technologies: Knowns, unknowns, and future prospects
por: Edgley, Katherine, et al.
Publicado: (2023)

The known knowns, known unknowns, and unknown unknowns of surveys and sleep
por: Shaker, Marcus, et al.
Publicado: (2022)

Resolution of Inflammation in Neurodegenerative Diseases: The Role of Resolvins
por: Chamani, Sajad, et al.
Publicado: (2020)

Statins as anti-pyroptotic agents
por: Khalifeh, Masoomeh, et al.
Publicado: (2021)

Risk of Transmissibility From Neurodegenerative Disease-Associated Proteins: Experimental Knowns and Unknowns
por: Asher, David M, et al.
Publicado: (2020)

Therapeutic induction of autophagy to modulate neurodegenerative disease progression
por: Hochfeld, Warren E, et al.
Publicado: (2013)

Phytochemicals as inhibitors of tumor necrosis factor alpha and neuroinflammatory responses in neurodegenerative diseases
por: Zahedipour, Fatemeh, et al.
Publicado: (2022)

Sepsis-related stress response: known knowns, known unknowns, and unknown unknowns
por: Peng, Jinmin, et al.
Publicado: (2010)

Known unknowns and unknown unknowns
por: Burki, Talha
Publicado: (2018)

Potential therapeutic interventions based on the role of the endoplasmic reticulum stress response in progressive neurodegenerative diseases
por: Puri, Basant K., et al.
Publicado: (2018)

Immune inflammatory modulation as a potential therapeutic strategy of stem cell therapy for ALS and neurodegenerative diseases
por: Kim, Seung Hyun, et al.
Publicado: (2018)

Current and future therapeutic strategies for the treatment of retinal neurodegenerative diseases
por: Maneu, Victoria, et al.
Publicado: (2021)

Free ubiquitin: a novel therapeutic target for neurodegenerative diseases
por: Park, Chul-Woo, et al.
Publicado: (2021)

Role of the NLRP3 inflammasome in neurodegenerative diseases and therapeutic implications
por: Duan, Yanhui, et al.
Publicado: (2020)

The known and the unknown
Publicado: (2010)

Geographic Translocation of Bats: Known and Potential Problems
por: Constantine, Denny G.
Publicado: (2003)

Mitophagy in yeast: known unknowns and unknown unknowns
por: Abeliovich, Hagai
Publicado: (2023)

Potential of kynurenine metabolites in drug development against neurodegenerative diseases
por: Kubicova, Lenka, et al.
Publicado: (2020)

Profiling neuroprotective potential of trehalose in animal models of neurodegenerative diseases: a systematic review
por: Yap, Kah Hui, et al.
Publicado: (2022)

Abscisic acid, a promising therapeutic molecule to prevent Alzheimer’s and neurodegenerative diseases
por: Sánchez-Pérez, Ana María
Publicado: (2019)

The effect of intravenous trehalose administration in a patient with multiple sulfatase deficiency
por: Radbakhsh, Shabnam, et al.
Publicado: (2023)

Non-Clinical Models for Neurodegenerative Diseases: Therapeutic Approach and Drug Validation in Animal Models
por: Fernandez, Caridad Ivette, et al.
Publicado: (2017)

Disease X and other unknowns
por: Honigsbaum, Mark
Publicado: (2019)

Known and unknown matter
por: Ellis, Jonathan Richard
Publicado: (1994)

The therapeutic potential of nerve growth factor combined with blood-brain barrier modulation by focused ultrasound for neurodegenerative disorders
por: Xhima, Kristiana, et al.
Publicado: (2021)

Hidradenitis suppurativa – known and unknown disease
por: Wieczorek, Marta, et al.
Publicado: (2018)

Nuclear sphingomyelin in neurodegenerative diseases
por: Albi, Elisabetta, et al.
Publicado: (2021)

The emerging epigenetics of PARK7 and its implication in neurodegenerative disease
por: Vavougios, George D., et al.
Publicado: (2018)

Renal denervation in the antihypertensive arsenal – knowns and known unknowns
por: Messerli, Franz H., et al.
Publicado: (2023)

Fatty Acids: An Insight into the Pathogenesis of Neurodegenerative Diseases and Therapeutic Potential
por: Vesga-Jiménez, Diego Julián, et al.
Publicado: (2022)

Modulating the distribution and fate of exogenously delivered MSCs to enhance therapeutic potential: knowns and unknowns
por: Masterson, Claire H., et al.
Publicado: (2019)

Umbilical Lesions: A Cluster of Known Unknowns and Unknown Unknowns
por: Das, Aditi
Publicado: (2019)

Nucleoredoxin-like 2 metabolic signaling impairs its potential contribution to neurodegenerative diseases
por: Corsi, Mariangela, et al.
Publicado: (2022)

Significance of intercellular communication for neurodegenerative diseases
por: Cihankaya, Hilal, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3i5j3g11ujhv0dk01g40lg3744